Year |
Citation |
Score |
2023 |
Ang Z, Paruzzo L, Hayer KE, Schmidt C, Torres-Diz M, Xu F, Zankharia U, Zhang Y, Soldan SS, Zheng S, Falkenstein CD, Loftus JP, Yang SY, Asnani M, King Sainos P, et al. Alternative splicing of its 5' UTR limits CD20 mRNA translation and enables resistance to CD20-directed immunotherapies. Blood. PMID 37683180 DOI: 10.1182/blood.2023020400 |
0.662 |
|
2023 |
Ang Z, Paruzzo L, Hayer KE, Schmidt C, Torres Diz M, Xu F, Zankharia U, Zhang Y, Soldan S, Zheng S, Falkenstein CD, Loftus JP, Yang SY, Asnani M, King Sainos P, et al. Alternative splicing of its 5'-UTR limits CD20 mRNA translation and enables resistance to CD20-directed immunotherapies. Biorxiv : the Preprint Server For Biology. PMID 37645778 DOI: 10.1101/2023.02.19.529123 |
0.662 |
|
2022 |
Closa A, Reixachs-Solé M, Fuentes-Fayos AC, Hayer KE, Melero JL, Adriaanse FRS, Bos RS, Torres-Diz M, Hunger SP, Roberts KG, Mullighan CG, Stam RW, Thomas-Tikhonenko A, Castaño JP, Luque RM, et al. A convergent malignant phenotype in B-cell acute lymphoblastic leukemia involving the splicing factor SRRM1. Nar Cancer. 4: zcac041. PMID 36518527 DOI: 10.1093/narcan/zcac041 |
0.647 |
|
2022 |
Yang SY, Hayer KE, Fazelinia H, Spruce LA, Asnani M, Black KL, Naqvi AS, Pillai V, Barash Y, Elenitoba-Johnson KSJ, Thomas-Tikhonenko A. FBXW7β isoform drives transcriptional activation of the proinflammatory TNF cluster in human pro-B cells. Blood Advances. PMID 36322817 DOI: 10.1182/bloodadvances.2022007910 |
0.663 |
|
2022 |
Heard A, Landmann JH, Hansen AR, Papadopolou A, Hsu YS, Selli ME, Warrington JM, Lattin J, Chang J, Ha H, Haug-Kroeper M, Doray B, Gill S, Ruella M, Hayer KE, et al. Antigen glycosylation regulates efficacy of CAR T cells targeting CD19. Nature Communications. 13: 3367. PMID 35690611 DOI: 10.1038/s41467-022-31035-7 |
0.399 |
|
2021 |
Zheng S, Gillespie E, Naqvi AS, Hayer KE, Ang Z, Torres-Diz M, Quesnel-Vallières M, Hottman DA, Bagashev A, Chukinas J, Schmidt C, Asnani M, Shraim R, Taylor DM, Rheingold SR, et al. Modulation of CD22 Protein Expression in Childhood Leukemia by Pervasive Splicing Aberrations: Implications for CD22-Directed Immunotherapies. Blood Cancer Discovery. PMID 35015683 DOI: 10.1158/2643-3230.BCD-21-0087 |
0.653 |
|
2021 |
Sehgal P, Lanauze C, Wang X, Hayer KE, Torres-Diz M, Leu NA, Sela Y, Stanger BZ, Lengner CJ, Thomas-Tikhonenko A. MYC hyperactivates WNT signaling in APC/CTNNB1-mutated colorectal cancer cells through miR-92a-dependent repression of DKK3. Molecular Cancer Research : McR. PMID 34593610 DOI: 10.1158/1541-7786.MCR-21-0666 |
0.571 |
|
2021 |
Schulz L, Torres-Diz M, Cortés-López M, Hayer KE, Asnani M, Tasian SK, Barash Y, Sotillo E, Zarnack K, König J, Thomas-Tikhonenko A. Direct long-read RNA sequencing identifies a subset of questionable exitrons likely arising from reverse transcription artifacts. Genome Biology. 22: 190. PMID 34183059 DOI: 10.1186/s13059-021-02411-1 |
0.627 |
|
2021 |
Lanauze CB, Sehgal P, Hayer K, Torres-Diz M, Pippin JA, Grant SFA, Thomas-Tikhonenko A. Colorectal cancer-associated Smad4 R361 hotspot mutations boost Wnt/β-catenin signaling through enhanced Smad4-LEF1 binding. Molecular Cancer Research : McR. PMID 33608451 DOI: 10.1158/1541-7786.MCR-20-0721 |
0.572 |
|
2019 |
Harrington CT, Sotillo E, Robert A, Hayer KE, Bogusz AM, Psathas J, Yu D, Taylor D, Dang CV, Klein PS, Hogarty MD, Geoerger B, El-Deiry WS, Wiels J, Thomas-Tikhonenko A. Correction: Transient stabilization, rather than inhibition, of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma. Leukemia. PMID 31758088 DOI: 10.1038/S41375-019-0650-2 |
0.67 |
|
2019 |
Asnani M, Hayer KE, Naqvi AS, Zheng S, Yang SY, Oldridge D, Ibrahim F, Maragkakis M, Gazzara MR, Black KL, Bagashev A, Taylor D, Mourelatos Z, Grupp SA, Barrett D, et al. Retention of CD19 intron 2 contributes to CART-19 resistance in leukemias with subclonal frameshift mutations in CD19. Leukemia. PMID 31591467 DOI: 10.1038/S41375-019-0580-Z |
0.669 |
|
2019 |
Harrington CT, Sotillo E, Robert A, Hayer KE, Bogusz AM, Psathas J, Yu D, Taylor D, Dang CV, Klein P, Hogarty MD, Geoerger B, El-Deiry WS, Wiels J, Thomas-Tikhonenko A. Transient stabilization, rather than inhibition, of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma. Leukemia. PMID 30914792 DOI: 10.1038/s41375-019-0454-4 |
0.679 |
|
2019 |
Zheng S, Naqvi AS, Bolton-Gillespie E, Asnani M, Hayer K, Barash Y, Thomas-Tikhonenko A. Pipeline for Discovering Neoepitopes Generated By Alternative Splicing in B-ALL Blood. 134: 1342-1342. DOI: 10.1182/Blood-2019-131277 |
0.712 |
|
2019 |
Li L, Hayer K, Xian L, Luo L, Cope L, Thomas-Tikhonenko A, Resar L. High Mobility Group A1 Chromatin Regulators Function As Critical Drivers of Leukemogenesis in Preclinical Models of Relapsed, Pediatric B-Cell ALL Blood. 134: 3946-3946. DOI: 10.1182/Blood-2019-130261 |
0.671 |
|
2018 |
Black KL, Naqvi AS, Asnani M, Hayer KE, Yang SY, Gillespie E, Bagashev A, Pillai V, Tasian SK, Gazzara MR, Carroll M, Taylor D, Lynch KW, Barash Y, Thomas-Tikhonenko A. Aberrant splicing in B-cell acute lymphoblastic leukemia. Nucleic Acids Research. PMID 30517739 DOI: 10.1093/nar/gky1231 |
0.628 |
|
2018 |
Black KL, Naqvi AS, Asnani M, Hayer KE, Yang SY, Gillespie E, Bagashev A, Pillai V, Tasian SK, Gazzara MR, Carroll M, Taylor D, Lynch KW, Barash Y, Thomas-Tikhonenko A. Aberrant splicing in B-cell acute lymphoblastic leukemia. Nucleic Acids Research. PMID 30357359 DOI: 10.1093/Nar/Gky946 |
0.714 |
|
2018 |
Singh N, Shestova O, Hayer K, Hong A, Ravikumar P, Hoshino A, Shalem O, Weitzman MD, June CH, Gill SI, Ruella M. CAR T Cell Cytotoxicity Is Dependent on Death Receptor-Driven Apoptosis Blood. 132: 698-698. DOI: 10.1182/Blood-2018-99-117328 |
0.441 |
|
2014 |
Lahens NF, Kavakli IH, Zhang R, Hayer K, Black MB, Dueck H, Pizarro A, Kim J, Irizarry R, Thomas RS, Grant GR, Hogenesch JB. IVT-seq reveals extreme bias in RNA sequencing. Genome Biology. 15: R86. PMID 24981968 DOI: 10.1186/Gb-2014-15-6-R86 |
0.326 |
|
2014 |
Hayer K, Pizarro A, Hogenesch J, Grant GR. Benchmark analysis of algorithms for determining expressed full length mRNA splice forms from RNA-Seq data F1000research. 5. DOI: 10.7490/F1000Research.1095381.1 |
0.305 |
|
Show low-probability matches. |